Factor IXa–Factor VIIIa complex (Intrinsic tenase complex)

The **Factor IXa–Factor VIIIa complex** (intrinsic tenase complex) is a membrane-associated multiprotein assembly essential for efficient blood clotting. Activated Factor IX (FIXa) forms a complex with its cofactor, activated Factor VIII (FVIIIa), on negatively charged phospholipid membranes in the presence of calcium ions. This complex proteolytically activates Factor X to Factor Xa, a critical amplification step in the intrinsic coagulation cascade. The efficiency of Factor X activation is increased by over a million-fold through complex formation, underpinning the physiological importance of this interaction. Disruption or deficiency of either component leads to bleeding disorders such as hemophilia A (FVIII deficiency) or hemophilia B (FIX deficiency). The tenase complex is a key therapeutic target for both procoagulant and anticoagulant drug strategies, and its activity is regulated naturally by inhibitors such as antithrombin, often with heparin as a cofactor[1][2][3][4][6].

Other names

intrinsic Xasetenase complexintrinsic tenaseFactor IXa–Factor VIIIa complexFIXa–FVIIIa complexXase complex

Direct enzymatic inhibition of Factor IXa (to reduce coagulation) Antibody-mediated bridging/mimicking of FVIIIa function (e.g., emicizumab) Anticoagulant potentiation (e.g., heparin-activated antithrombin binds and inhibits FIXa, disrupting tenase complex formation)